Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px
Document › Details

Protagen AG. (7/2/13). "Press Release: Protagen AG Sells Service Business". Dortmund.

Organisations Organisation Protagen AG
  Organisation 2 Protagen Protein Services GmbH (PPS)
  Group Zukunftsfonds Heilbronn (Group)
Products Product proteomic services
  Product 2 venture capital
Index terms Index term Protagen–Zukunftsfonds Heilbronn: investment, 201307 acquisition of Protagen Protein Services GmbH by Zukunftsfonds Heilbronn
  Index term 2 Panatecs–Zukunftsfonds Heilbronn: investment, 200903 financing round totalling €5m KfW Mittelstandsbank + Zukunftsfonds Heilbronn
Persons Person Müllner, Stefan (Fundamenta Life-Sciences GmbH 201711 General Manager + Partner before Protagen –201610 CEO)
  Person 2 Lautscham, Georg (Protagen 201610– CEO before CBO)
     


Protagen AG, Dortmund, divested its 100% subsidiary Protagen Protein Services GmbH (PPS), to Zukunftsfonds Heilbronn. The company was spun out in January 2012 and continued the business of the former operational division Protein Services, which accumulated unique expertise in the GMP-compliant protein analytics over the years.

"The sale of this profitable service business to a potent investor with complementary portfolio companies secures a sustainable growth for PPS, an internationally renowned specialist for protein characterization and biosimilar comparability. On the other hand, the capital injection generated by this transaction is a solid mid-term financing opportunity for the Protagen strategy in the area of novel diagnostics, i.e. Dx and CDx, and enables to start the development of own products for this growing market immediately. With this step, Protagen positions itself as highly attractive target for new VC investors", states Dr. Stefan Müllner, CEO.


About Protagen

PROTAGEN AG is a leading specialist in the development of novel diagnostic tests in autoimmune diseases. The company focuses its assay development programs on disease specific autoantibodies.
PROTAGEN expects to become the dominating provider for novel products in autoimmune-Dx and CDx.


Contact
Dr. Stefan Müllner
CEO
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
T: +49 (0) 231 9742 6300
F: +49 (0) 231 9742 6301
bd@protagen.com

Press Inquiries
Dr. Georg Lautscham
CBO
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
T:+49 (0) 231 9742 6300
F:+49 (0) 231 9742 6301
bd@protagen.com

   
Record changed: 2016-01-10

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Oncimmune (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px




» top